The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously received mRNA vaccines.
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback